D. Halpin (Exeter Devon, United Kingdom), S. Everaerts (Leuven, Belgium)
Late Breaking Abstract - High-sensitivity troponin I predicts all-cause mortality in stable COPD in the COSYCONET cohort
B. Waschki (Hamburg, Germany), P. Alter (Marburg, Germany), T. Zeller (Hamburg, Germany), C. Magnussen (Hamburg, Germany), R. Twerenbold (Hamburg, Germany), S. Blankenberg (Hamburg, Germany), A. Omlor (Homburg Saar, Germany), C. Herr (Homburg Saar, Germany), K. Rabe (Grosshansdorf, Germany), T. Welte (Hannover, Germany), R. Jörres (München, Germany), C. Vogelmeier (Marburg, Germany), R. Bals (Homburg Saar, Germany), H. Watz (Grosshansdorf, Germany)
|  |
Disease progression patterns in COPD
F. Bragman (London, United Kingdom), A. Young (London, United Kingdom), D. Hawkes (London, United Kingdom), D. Alexander (London, United Kingdom), J. Hurst (London, United Kingdom)
|  |
Longitudinal stability and association with all-cause mortality of the 2017 GOLD groups in the ECLIPSE cohort
M. Faner Canet (Barcelona, Spain), G. Noell (Barcelona, Spain), P. Bakke (Bergen, Norway), E. K. Silverman (Boston, United States of America), R. Tal-Singer (Collegeville, United States of America), A. Agusti (Barcelona, Spain)
|  |
The value of short physical performance battery (SPPB) as an alternative component of the BODE Index in predicting death in chronic obstructive pulmonary disease (COPD) in the ERICA cohort.
J. Fermont (Cambridge, United Kingdom), M. Fisk (Cambridge, United Kingdom), C. Bolton (Nottingham, United Kingdom), J. Cockroft (Cardiff, United Kingdom), C. Mceniery (Cambridge, United Kingdom), J. Fuld (Cambridge, United Kingdom), D. Mohan (Collegeville, United States of America), R. Tal-Singer (Collegeville, United States of America), H. Mullerova (Uxbridge, United Kingdom), A. Wood (Cambridge, United Kingdom), I. Wilkinson (Cambridge, United Kingdom), M. Polkey (London, United Kingdom)
| |
Soluble urokinase plasminogen activator receptor (suPAR) predicts mortality in exacerbated COPD
D. Jørgensen ( Hvidovre, Denmark), N. Godtfredsen (Hvidovre, Denmark), K. Marsaa (Herlev, Denmark), C. Ulrik (Hvidovre, Denmark), O. Andersen (Hvidovre, Denmark), J. Eugen-Olsen (Hvidovre, Denmark), L. Rasmussen (Hvidovre, Denmark)
| |
Role of different spirometric reference equations for lung volumes assessment
G. Imeri (Milan, Italy), F. Braido (Genova, Italy), M. Contoli (Ferrara, Italy), A. Corsico (Pavia, Italy), F. Di Marco (Milan, Italy), C. Micheletto (Legnago, Italy), G. Pelaia (Catanzaro, Italy), P. Rogliani (Rome, Italy), R. Trapasso (Milan, Italy), P. Santus (University of Milan, Respiratory Unit, L. Sacco Hospital, ASST Fatebenefratelli Saccoan, Italy), N. Scichilone (Palermo, Italy), P. Solidoro (Turin, Italy), G. Sotgiu (Sassari, Italy)
|  |
Novel spirometry indices detect mild airflow obstruction not detected by traditional criteria
S. Bhatt (Birmingham, United States of America), N. Bhakta (San Francisco, United States of America), C. Wilson (Denver, United States of America), C. Cooper (Los Angeles, United States of America), I. Barjaktarevic (Los Angeles, United States of America), S. Bodduluri (Birmingham, United States of America), Y. Kim (Birmingham, United States of America), M. Eberlein (Iowa City, United States of America), P. Woodruff (San Francisco, United States of America), F. Sciurba (Pittsburgh, United States of America), P. Castaldi (Boston, United States of America), M. Han (Ann Arbor, United States of America), M. Dransfield (Birmingham, United States of America), A. Nakhmani (Birmingham, United States of America)
| |
Clinical clustering of COPD patients is useful to predict future COPD exacerbations
A. Malinovschi (Uppsala, Sweden), C. Janson (Uppsala, Sweden), K. Bröms (Gävle, Sweden), B. Ställberg (Uppsala, Sweden), K. Lisspers (Uppsala, Sweden), M. Högman (Uppsala, Sweden)
| |